Loading company…
Nanjing Tengchen Biotechnology develops diagnostic technologies and products for cancer detection and monitoring.
Founded in 2018 and based in Nanjing, Nanjing Tengchen Biotechnology, also known as Tantica, develops tumor diagnostic technologies. Its services include early cancer diagnosis, prognosis and treatment assessment, and recurrence monitoring. The company has a 1,600-square-meter research and development center and medical testing laboratory.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in